T 0243/22 (Rucaparib maleate/PFIZER) of 27.02.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T024322.20250227
- Date of decision
- 27 February 2025
- Case number
- T 0243/22
- Petition for review of
- -
- Application number
- 16183844.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE
- Applicant name
- Pfizer Inc.
- Opponent name
- Generics [UK] Ltd
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of the claims of the main request, filed as auxiliary request 3 with the statement of grounds of appeal, and, if necessary, a description and drawings to be adapted thereto.